N-α,N-ω-,N-ω′-Tri-Z-L-arginine

N-α,N-ω-,N-ω′-Tri-Z-L-arginine is a protected L-arginine derivative in which the α-amino group and the two guanidinium-related nitrogens are masked as Z (benzyloxycarbonyl) carbamates, yielding a tri-Z protected, highly functionalized amino acid building block. The molecule retains the L-configuration at the α-carbon and presents an arginine backbone with a protected side-chain that is chemically stable under many peptide coupling conditions while remaining amenable to controlled deprotection. The benzyloxycarbonyl groups introduce aromatic carbamate functionality that can be removed in a planned sequence to regenerate the free amino and guanidinium functionalities for subsequent amide bond formation and salt-formation chemistry. The resulting reactivity profile supports peptide synthesis compatibility and downstream derivatization where orthogonal unmasking of arginine's cationic side chain is required for stereochemically defined peptidic architectures.

1. Peptide Synthesis

N-α,N-ω-,N-ω′-Tri-Z-L-arginine serves as an arginine-protected peptide building block for stepwise solid-phase or solution-phase peptide coupling, where tri-Z protection suppresses side-chain guanidinium reactivity during amide bond formation. The preserved L-configuration at the α-stereocenter and the masked guanidine nitrogens reduce undesired salt formation and side reactions, supporting clean incorporation of arginine residues into peptide chains. Z-protected carbamates can be removed under conditions compatible with peptide integrity, enabling sequential unmasking to generate the free guanidinium for final peptide assembly or for late-stage functionalization. The compound therefore functions as a practical intermediate for preparing arginine-rich peptides, including sequences that require controlled exposure of the cationic side chain for binding and solubility tuning in peptide science.

2. Chemical Biology

N-α,N-ω-,N-ω′-Tri-Z-L-arginine supports chemical biology workflows that require defined arginine side-chain chemistry for probing protein-peptide recognition and nucleic-acid-related interactions. The tri-Z masking strategy stabilizes the guanidinium functionality during synthesis of labeled or modified peptide probes, while planned deprotection can regenerate the strongly basic arginine group for electrostatic and hydrogen-bonding interactions. The benzyloxycarbonyl groups enable downstream derivatization strategies that depend on orthogonal functional group presentation, such as converting the arginine residue into a conjugation-ready handle after peptide assembly. The compound can be employed to generate arginine-containing molecular probes and biochemical research intermediates where stereodefined amino acid incorporation and controlled side-chain reveal are required.

3. Bioconjugation Chemistry

N-α,N-ω-,N-ω′-Tri-Z-L-arginine is suitable for bioconjugation-oriented synthesis of arginine-bearing linkers and peptide conjugates where a protected guanidinium group must survive coupling and purification steps. The tri-carbamate protection provides a means to control the timing of guanidinium deprotection, allowing conjugation chemistries to proceed without premature cationic reactivity or aggregation. The compound's protected amine and side-chain nitrogens can be unmasked to furnish a free, protonatable guanidinium that participates in salt formation and can improve solubility and binding in conjugate formats. The resulting arginine-containing intermediates can be carried forward to construct bioconjugates for affinity reagents, cell-surface targeting peptides, and research-grade labeling scaffolds.

4. Peptidomimetics And SAR

N-α,N-ω-,N-ω′-Tri-Z-L-arginine can be used in peptidomimetic construction and structure-activity relationship studies where arginine's guanidinium geometry and basicity must be introduced with stereochemical fidelity. The L-arginine backbone and protected side-chain enable assembly of analog libraries in which arginine is retained as a key pharmacophore while other positions are varied, supporting systematic SAR exploration of charge distribution and hydrogen-bonding patterns. Z-protection allows synthetic handling during iterative coupling and purification, and subsequent deprotection can restore the cationic side-chain for comparing binding-relevant properties across analogs. The compound thereby functions as a chiral intermediate for generating arginine-centered mimetics and SAR-focused peptide analogs used in medicinal chemistry and molecular design.

5. Pharmaceutical Manufacturing

N-α,N-ω-,N-ω′-Tri-Z-L-arginine is applicable to pharmaceutical manufacturing workflows that require reproducible incorporation of protected arginine residues into peptide or peptide-like intermediates under controlled process chemistry. The tri-Z protection strategy supports stable handling of a strongly basic side chain during upstream synthesis, reducing process sensitivities associated with guanidinium salts and side reactions. Planned deprotection steps can be integrated into a manufacturing route to regenerate the free arginine functionality at defined stages, supporting consistent downstream formation of active peptide intermediates or conjugate precursors. The compound can be employed as a defined, stereochemically controlled building block for producing arginine-containing intermediates used in fine chemical synthesis and applied peptide manufacturing operations.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die